Researcher
Sayan Chakraborty obtained his PhD degree from the Rosalind Franklin University of Medicine and Science, US, and joined A*STAR’s Institute of Molecular and Cell Biology (IMCB) in late 2012. He is currently a Senior Research Scientist at IMCB and his research interests include identifying targets for cancer therapy, developing antibody-based treatments for cancer and understanding tumour-extracellular matrix signalling.
Related Articles
Unleashing skin’s healing superpowers
17 Jan 2023A protein called Agrin naturally produced in the skin could soon be the active ingredient
Out for blood in the fight against cancer
30 Sep 2019By interfering with the production and downstream activity of a molecule called Agrin in tumors,



